SEARCH

SEARCH BY CITATION

References

  • Aucella, F., De Bonis, P., Gatta, G., Muscarella, L.A., Vi gilante, M., di Giorgio, G., D’Errico, M., Zelante, L., Stallone, C. & Bisceglia, L. (2005) Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis. Nephron. Clin. Pract. 99, c31c36.
  • Awad, A.S., Huang, L., Ye, H., Duong, E.T., Bolton, W.K., Linden, J. & Okusa, M.D. (2006) Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 290, F827F837.
  • Bausch-Jurken, M.T., Mahnke-Zizelman, D.K., Morisaki, T. & Sabina, R.L. (1992) Molecular cloning of AMP deaminase isoform L. Sequence and bacterial expression of human AMPD2 cDNA. J. Biol. Chem. 267, 2240722413.
  • Bogusky, R.T., Steele, K.A. & Lowenstein, L.M. (1981) The purine nucleotide cycle in the regulation of ammoniagenesis during induction and cessation of chronic acidosis in the rat kidney. Biochem. J. 196, 323326.
  • Caridi, G., Bertelli, R., Perfumo, F. & Ghiggeri, G.M. (2004) Heterozygous NPHS1 or NPHS2 mutations in responsive nephrotic syndrome and the multifactorial origin of proteinuria. Kidney Int. 66, 17151716.
  • Friedman, D.J., Rennke, H.G., Csizmadia, E., Enjyoji, K. & Robson, S.C. (2007) The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 56, 23712379.
  • Fukui, H., Taniguchi, S., Ueta, Y., Yoshida, A., Ohtahara, A., Hisatome, I. & Shigemasa, C. (2001) Enhanced activity of the purine nucleotide cycle of the exercising muscle in patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 86, 22052210.
  • Ghiggeri, G.M., Bruschi, M., Candiano, G., Rastaldi, M.P., Scolari, F., Passerini, P., Musante, L., Pertica, N., Caridi, G., Ferrario, F., Perfumo, F. & Ponticelli, C. (2003) Depletion of clusterin in renal diseases causing nephrotic syndrome. Kidney Int. 62, 21842194.
  • Gill, A., Wortham, K., Costa, D., Davis, W., Ticho, B. & Whalley, E. (2009) Protective effect of Tonapofylline (BG9928), an adenosine A 1 receptor antagonist, against cisplatin-induced acute kidney injury in rats. Am. J. Nephrol. 30, 521526.
  • Goodarzi, M.O., Taylor, K.D., Guo, X., Quinones, M.J., Cui, J., Li, X., Hang, T., Yang, H., Holmes, E., Hsueh, W.A., Olefsky, J. & Rotter, J.I. (2005) Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait. Diabetes 54, 12221227.
  • Haas, A.L. & Sabina, R.L. (2003) N-terminal extensions of the human AMPD2 polypeptide influence ATP regulation of isoform L. Biochem. Biophys. Res. Commun. 305, 421427.
  • Hanisch, F., Hellsten, Y. & Zierz, S. (2006) Ecto- and cytosolic 5’-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle. Biol. Chem. 387, 5358.
  • Hellsten, Y., Richter, E.A., Kiens, B. & Bangsbo, J. (1999) AMP deamination and purine exchange in human skeletal muscle during and after intense exercise. J. Physiol. 520, 3.
  • Kalsi, K.K., Yuen, A.H., Rybakowska, I.M., Johnson, P.H., Slominska, E., Birks, E.J., Kaletha, K., Yacoub, M.H. & Smolenski, R.T. (2003) Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation – a potential mechanism of protection in heart failure. Cardiovasc. Res. 59, 678684.
  • Korzeniewski, B. (2006) AMP deamination delays muscle acidification during heavy exercise and hypoxia. J. Biol. Chem. 281, 30573066.
  • Lahdenkari, A.T., Kestila, M., Holmberg, C., Koskimies, O. & Jalanko, H. (2004) Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS). Kidney Int. 65, 18561863.
  • Loh, E., Rebbeck, T.R., Mahoney, P.D., DeNofrio, D., Swain, J.L. & Holmes, E.W. (1999) Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 99, 14221425.
  • Mahnke-Zizelman, D.K. & Sabina, R.L. (2002) N-terminal sequence and distal histidine residues are responsible for pH-regulated cytoplasmic membrane binding of human AMP deaminase isoform E. J. Biol. Chem. 277, 4265442662.
  • Morisaki, T., Gross, M., Morisaki, H., Pongratz, D., Zoellner, N. & Holmes, E.W. (1992) Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc. Natl Acad. Sci. USA 89, 64576461.
  • Morisaki, T. & Holmes, E.W. (1993) Functionally distinct elements are required for expression of the AMPD1 gene in myocytes. Mol. Cell. Biol. 13, 58545860.
  • Mundel, P., Reiser, J., Zúñiga Mejía Borja, A., Pavenstädt, H., Davidson, G.R., Kriz, W. & Zeller, R. (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236, 248258.
  • Norman, B., Hellsten-Westing, Y., Sjödin, B. & Jansson, E. (1994) AMP deaminase in skeletal muscle of healthy males quantitatively determined by new assay. Acta Physiol. Scand. 150, 397403.
  • Nowak, G. & Kaletha, K. (1992) Purification and properties of AMP-deaminase from human kidney. Biochem. Med. Metab. Biol. 47, 232241.
  • Ogasawara, N., Goto, H., Watanabe, T., Kawamura, Y. & Yoshino, M. (1974) Multiple forms of AMP deaminase in various rat tissues. FEBS Lett. 44, 6366.
  • Operti, M.G., Vincent, M.F., Brucher, J.M. & Van den Berghe, G. (1998) Muscle purine nucleotide cycle enzymes in exercise intolerance. Adv. Exp. Med. Biol. 431, 205209.
  • Qiu, F.H., Wada, K., Stahl, G.L. & Serhan, C.N. (2000) IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment. Proc. Natl Acad. Sci. USA 97, 42674272.
  • Schnermann, J. & Briggs, J.P. (2008) Tubuloglomerular feedback – Mechanistic insights from gene-manipulated mice. Kidney Int. 74, 418426.
  • Sermsuvitayawong, K., Wang, X., Nagabukuro, A., Matsuda, Y., Morisaki, H., Toyama, K., Mukai, T. & Morisaki, T. (1997) Genomic organization of Ampd3, heart-type AMPD gene, located in mouse chromosome 7. Mamm. Genome 8, 767769.
  • Stepinski, J., Pawelczyk, T., Bizon, D. & Angielski, S. (1996) Purine nucleotide cycle in rat renal cortex and medulla under conditions that mimic normal and low oxygen supply. Kidney Int. 50, 11951201.
  • Szydlowska, M., Chodorowski, Z., Rybakowska, I., Nagel-Starczynowska, G. & Kaletha, K. (2004) Full-size form of human liver AMP-deaminase? Mol. Cell. Biochem. 266, 133137.
  • Tavazzi, B., Di Pierro, D., Amorini, A.M., Fazzina, G., Tuttobene, M., Giardina, B. & Lazzarino, G. (2000) Energy metabolism and lipid peroxidation of human erythrocytes as a function of increased oxidative stress. Eur. J. Biochem. 267, 684689.
  • Van den Berg, J.G., Van den Bergh Weerman, M.A., Assmann, K.J., Weening, J.J. & Florquin, S. (2004) Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int. 66, 19011906.
  • Van den Berghe, G., Bontemps, F., Vincent, M.F. & Van den Bergh, F. (1992) The purine nucleotide cycle and its molecular defects. Prog. Neurobiol. 39, 547561.
  • Wagner, M.C., Rhodes, G., Wang, E., Pruthi, V., Arif, E., Saleem, M.A., Wean, S.E., Garg, P., Verma, R., Holzman, L.B., Gattone, V., Molitoris, B.A. & Nihalani, D. (2008) Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1. J. Biol. Chem. 51, 3557935589.
  • Wang, X., Morisaki, H., Sermsuvitayawong, K., Mineo, I., Toyama, K., Ogasawara, N., Mukai, T. & Morisaki, T. (1997) Cloning and expression of cDNA encoding heart-type isoform of AMP deaminase. Gene 188, 285290.
  • Wolf, G. & Stahl, R.A. (2003) CD2-associated protein and glomerular disease. Lancet 362, 17461748.
  • Yamada, Y., Goto, H., Murase, T. & Ogasawara, N. (1994a) Gene mutations for human erythrocyte AMP deaminase deficiency. Adv. Exp. Med. Biol. 370, 703706.
  • Yamada, Y., Goto, H., Murase, T. & Ogasawara, N. (1994b) Molecular basis for human erythrocyte AMP deaminase deficiency: screening for the major point mutation and identification of other mutations. Hum. Mol. Genet. 3, 22432245.
  • Yamada, Y., Goto, H. & Ogasawara, N. (1994a) A point mutation responsible for human erythrocyte AMP deaminase deficiency. Hum. Mol. Genet. 3, 331334.